Introduction
BC WORLD PHARMACEUTICAL is constantly striving to develop
the next generation of medicines in the future.
Higher R&D investment
than domestic top pharmaceutical companies
Average
15%
- Sales
- R&D expenses
- Pharmaceutical R&D Ratio of BC WORLD PHARMACEUTICAL
Pangyo GRI
Medicine development with innovative technology,
development of methods for evaluating pharmaceuticals
and its technology transfer, and design and execution for clinical trials
Yeoju Central Research Institute
Testing process optimization new product
and validation scale-up and technology transfer